from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0390/-

LFCtreatmentdescriptionclass of inhibitor

0.451

Amikacinug/mL Amikacintranslation

0.860

Cap5-10ug/mL Capreomycintranslation

0.587

Rox10-50 ug/mL Roxithromycintranslation

-0.566

SM2-5 ug/mL Streptomycintranslation

-0.026

Tet5-10 ug/mL Tetracyclinetranslation

0.753

Rif0.2-5ug/mL Rifampicintranscription

0.255

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.699

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.216

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.499

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.813

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.171

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.610

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.111

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.461

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.106

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.592

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.878

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.348

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.713

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.480

KCN5-20 ug/mL Potassium cyaniderespiration

-0.738

NaN30.2-2 mM Sodium aziderespiration

0.247

Nigericin50 uM Nigericinrespiration

0.098

TRC10-150 ug/mL Triclosanrespiration

-0.988

TRZ10-25 ug/mL Thioridazinerespiration

-2.217

Valinomycin0.5-10 uM Valinomycinrespiration

1.085

ZnSO42 mM ZnSO4respiration

-0.033

menadione6-10 ug/mL Menadionerespiration

-0.319

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.694

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.287

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.320

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.027

NRP_1Non-replicating persistence stage 1dosRassociated

0.110

Amp0.2mg/mL AmpicillincellWall

0.421

Cephalexin20-100 ug/mL CephalexincellWall

0.665

Cerulenin0.32-5 ug/mL CerulenincellWall

0.490

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.178

EMB10-20 ug/mL EthambutolcellWall

0.354

Eta12-40 ug/mL EthionamidecellWall

0.658

INH0.2-0.4 ug/mL IsoniazidcellWall

0.040

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.440

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.713

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.501

BZA0.12 mg/mL BenzamidearomaticAmides

-0.178

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.083

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.412

H2O24 mM hydrogen peroxideDNAdamaging

0.465

Levo10 ug/mL LevofloxacinDNAdamaging

0.832

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.595

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.388

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.929

UVUV-irradiationDNAdamaging

-0.625

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.226

Antimycin12.5-50 ug/mL Antimycin A?

0.709

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.612

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.733

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.471

PA8240.2-2 ug/mL PA-824?

-0.352

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.663

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.351

Verapamil50 uM Verapamil?

-0.268

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.451

methoxatin10-20 ug/mL Methoxatin?